Results 371 to 380 of about 1,451,429 (415)
Some of the next articles are maybe not open access.

Nasopharyngeal carcinoma in the young

Clinical Oncology, 1993
This study was carried out to determine whether locoregional control of nasopharyngeal carcinoma in the young by irradiation has improved since 1975. Fifty-seven consecutive, previously untreated, patients, less than 30 years old, were diagnosed and treated at University of Toronto Hospitals between 1958 and 1990; 21 patients were treated before and 36
Diponkar Banerjee   +4 more
openaire   +3 more sources

Exosomes in nasopharyngeal carcinoma

Clinica Chimica Acta, 2021
Nasopharyngeal carcinoma (NPC) is a malignant epithelial tumor with a unique geographical distribution, primarily prevalent in East Africa and Asia. Although there is an increased understanding of the pathogenesis and risk factors of NPC, prevention and treatment efforts remain limited. Various studies have indicated that exosomes are actively involved
Jianping Wen   +3 more
openaire   +3 more sources

Epidemiology of nasopharyngeal carcinoma

Seminars in Cancer Biology, 2002
Nasopharyngeal carcinoma (NPC) is a rare malignancy in most parts of the world, with an incidence well under 1 per 100,000 person-years. Exceptions are the Chinese, especially the Cantonese living in the central region of Guangdong Province in Southern China.
Jian-Min Yuan, Mimi C. Yu
openaire   +3 more sources

Nasopharyngeal carcinoma

Annals of Diagnostic Pathology, 1999
Nasopharyngeal carcinoma represents a morphologic spectrum of neoplasms localized to the nasopharynx and arising from nasopharyngeal epithelium. Nasopharyngeal carcinomas have rather unique clinical, epidemiologic, pathologic, and biologic features.
openaire   +2 more sources

Management of Nasopharyngeal Carcinoma

2016
© Springer International Publishing Switzerland 2011, 2016. Nasopharyngeal carcinoma is a distinctly radiosensitive and chemosensitive tumor. Best quality radiotherapy is demanded to build up the complex concave high-dose zone for this critical location.
Lee, WMA   +5 more
openaire   +5 more sources

Advances in nasopharyngeal carcinoma

Current Opinion in Oncology, 2005
Intergroup 0099 established the role of concurrent chemotherapy with radiation therapy in the treatment of locally advanced nasopharyngeal carcinoma, but its reproducibility was unclear and chemotherapy compliance was poor. Multiple concurrent chemoradiation phase III trials were initiated in response to the Intergroup trial, and technologic advances ...
W O'Meara, Nancy Y. Lee
openaire   +3 more sources

Nasopharyngeal carcinoma: an evolving paradigm

Nature Reviews Clinical Oncology, 2021
K. Wong   +11 more
semanticscholar   +1 more source

Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial

Nature Network Boston, 2021
H. Mai   +36 more
semanticscholar   +1 more source

Nasopharyngeal carcinoma in children

International Journal of Pediatric Otorhinolaryngology, 2000
Nasopharyngeal carcinoma (NPC) is rare in children. We report two cases from KK Women and Children's Hospital in Singapore, who presented with advanced locoregional disease. The various aspects of NPC in children are discussed. It is more common in males and black adolescents. The etiology is probably different from that in adult.
Henry K.K. Tan, Y.K Ong
openaire   +3 more sources

Nasopharyngeal Carcinomas in Children

Archives of Surgery, 1967
MALIGNANT neoplasms of the nasopharynx are uncommon in children. In Dargeon's review of 506 cases of childhood malignancies, only 27 were primary in the nasopharynx.1 In order of incidence, nasopharyngeal malignant neoplasms ranked behind neoplasms of bone, reticuloendothelial system, soft tissue, the eye and orbit, and the genitourinary tract ...
Don K. Weaver   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy